Sudeep Pharma IPO Allotment Finalised: What Does Latest GMP Indicate? Check Listing Date

Sudeep Pharma IPO GMP Today, Listing Date: The allotment of the Sudeep Pharma IPO has been finalised. Now, all eyes are on its listing, which will take place tomorrow, November 28, on both the BSE and the NSE. According to market observers, its grey market premium (GMP) has fallen by 7.2% to Rs 90 (or nearly 15% premium over the issue price) on Thursday, compared with Rs 97 recorded on Wednesday.

Investors can check the allotment status on the websites of BSE, the NSE, as well as on the portal of registrar MUFG Intime India Pvt Ltd.

The Sudeep Pharma IPO, which closed on Tuesday, received 93.71x subscription, garnering bids for 99,00,86,575 shares as against the 1,05,64,927 shares on offer. Its retail category got a 15.65x subscription, while

its non-institutional investor (NII) quota got a 116.72x subscription. The QIB category received a 213.08x subscription.

Sudeep Pharma IPO GMP Today

Its grey market premium has fallen to Rs 90, compared with Rs 97 on Wednesday.

According to market observers, unlisted shares of Sudeep Pharma Ltd are currently trading at Rs 683 apiece in the grey market, against the upper IPO price of Rs 593. It means a grey market premium (GMP) of nearly 15.18%, indicating moderate listing gains for investors.

The GMP is based on market sentiments and keeps changing. ‘Grey market premium’ indicates investors’ readiness to pay more than the issue price.

The price band of the Rs 895-crore IPO has been fixed at Rs 563-593 per equity share.

Sudeep Pharma IPO Listing Date

The company’s shares are proposed to be listed on both the NSE and the BSE on November 28, 2025.

Sudeep Pharma IPO Allotment Today: A Step-By-Step Guide To Check Status Online

The Sudeep Pharma IPO allotment has been finalised. The allotment status can be checked online by following these steps:

1) Visit registrar MUFG Intime India’s portal – https://in.mpms.mufg.com/Initial_Offer/public-issues.html.

2) Under ‘Select Company’, select ‘Sudeep Pharma Ltd’ in the drop box.

3) Enter your the Permanent Account Number (PAN), application number, DP ID, or account-IFSC number.

5) Then, click on the ‘Submit’ button.

Your share application status will appear on your screen.

Via the BSE

1) Go to the official BSE website via the URL — https://www.bseindia.com/investors/appli_check.aspx.

2) Under ‘Issue Type’, select ‘Equity’.

3) Under ‘Issue Name’, select ‘Sudeep Pharma Ltd’ in the drop box.

4) Enter your application number, or the Permanent Account Number (PAN). Those who want to check their allotment status via PAN can select the ‘Permanent Account Number’ option.

5) Then, click on the ‘I am not a robot’ to verify yourself and hit the ‘Search’ option.

Your share application status will appear on your screen.

On NSE’s Website

The allotment status can also be checked on the NSE’s website at https://www.nseindia.com/invest/check-trades-bids-verify-ipo-bids.

Sudeep Pharma IPO: More Details

The three-day initial public offering (IPO) concluded on November 25. Investors can bid for a minimum of 25 equity shares and in multiples of 25 shares thereafter, the company said in a statement.

The IPO is a mix of a fresh issue of equity shares worth Rs 95 crore and an offer for sale of nearly 1.35 crore equity shares aggregating worth Rs 800 crore by promoters, Sujit Jaysukh Bhayani, Sujeet Jaysukh Bhayani HUF, Shanil Sujit Bhayani and Avani Sujit Bhayani.

The net proceeds from the fresh issue to the tune of Rs 75.81 crore will be for capital expenditure towards procurement of machinery for its production line located at Nandesari Facility 1, Gujarat and general corporate purposes.

Sudeep Pharma is a technology-led manufacturer of excipients and specialty ingredients for the pharmaceutical, food and nutrition industries and is dedicated to contributing to the global healthcare ecosystem.

The company is one of the largest producers of food-grade iron phosphate for infant nutrition, clinical nutrition, and the food and beverage sectors, in terms of production capacity with a combined annual available manufacturing capacity of 72,246 metric tons, as of June 30, 2025, as per F&S report.

It has served over 1,100 customers, and has built longstanding relationships with marquee customers including Pfizer Inc, Mankind Pharma, Merck Group, Aurobindo Pharma, Cadila Pharmaceutical, IMCD Asia Pte Ltd, and Danone SA.

The company’s shares are proposed to be listed on the BSE and NSE.

ICICI Securities Ltd and IIFL Capital Services are the book-running lead managers, and MUFG Intime India Pvt Ltd is the registrar of the IPO.